Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease
Am J Nephrol
.
2024 Feb 28:1-4.
doi: 10.1159/000536540.
Online ahead of print.
Authors
Alaa T Makawi
1
2
,
Yahya M K Tawfik
1
3
,
Dave L Dixon
4
,
Gearoid M McMahon
5
,
Leo F Buckley
1
Affiliations
1
Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
2
Department of Pharmacy Practice, College of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia.
3
Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
4
Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, Virginia, USA.
5
Division of Renal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
PMID:
38417403
DOI:
10.1159/000536540
No abstract available
Keywords:
Implementation; Population health; SGLT2 inhibitors.